February 28th is Rare Disease Day. Although individually uncommon, rare diseases are estimated to impact 25-30 million Americans. For these patients, innovation isn't just an exciting advancement—it's often the difference between having or not having treatment options. Behind every rare disease trial, there are researchers, sponsors, CROs, and sites working together to bring new treatments forward. But most importantly, there are patients and families who are counting on all of us to get it right. Today, we recognize them and stay committed to doing our part.
PharPoint Research, Inc.
研究服务
Durham，NC 18,748 位关注者
We're a contract research organization (CRO) that helps innovative clients meet their clinical trial goals.
关于我们
PharPoint Research is an award-winning, client-focused contract research organization (CRO) with offices in the Research Triangle Park and Wilmington, NC. We provide nimble drug development solutions to clients of all sizes and have supported over 1,000 studies since 2007. PharPoint's services include: clinical operations, project management, data management, medical monitoring, biostatistics, statistical programming, medical writing, and study rescue. ---- RECRUITMENT FRAUD ALERT: Unsuspecting job seekers have reported receiving unsolicited contacts by phone, email, text, online recruitment services (including LinkedIn) and bogus websites from individual(s) purporting to be or represent PharPoint recruiters. Be advised that PharPoint does not extend unsolicited employment offers and all candidates must go through a formal interview process to be considered for an offer of employment. Full statement: https://pharpoint.com/careers/recruitment-fraud-alert/
- 网站
-
https://pharpoint.com
PharPoint Research, Inc.的外部链接
- 所属行业
- 研究服务
- 规模
- 51-200 人
- 总部
- Durham，NC
- 类型
- 私人持股
- 创立
- 2007
- 领域
- Clinical Data Management、Biostatistics、Project Management、Clinical Monitoring、Statistical Programming、Medical Writing和Medical Monitoring
地点
PharPoint Research, Inc.员工
动态
-
Looking for clinical data management (DM) support for a current or upcoming study? PharPoint offers flexible outsourcing options for clients – whether you're looking for full support from startup to database lock, or you just need an extra layer of support to help manage your current DM CRO, our team is happy to help! For more information about working with PharPoint and how our team can help you meet study goals, reach out!
-
-
The Orphan Drug Designation (ODD) offers significant benefits to companies developing new investigational products targeting rare diseases – but navigating the nuances of eligibility and the application process can be complex. ?? Swipe to explore four things to keep in mind as you prepare your application. (Interested in receiving tailored guidance from an experienced regulatory consultant? Reach out to our team to see how PharPoint can support your needs.)
-
CDM, CDP, CRF, CRO... clinical research is full of acronyms. ?? We've put together a quick reference guide with 66 common acronyms you're likely to encounter in the industry and what they mean. Bookmark it, share it, and never get lost in the alphabet soup again: ?? https://lnkd.in/eS_uaxgK?
-
We're wrapping up our series with Dr. Jane Cooke Wright, a trailblazer in cancer research and treatment. Dr. Wright was one of the first researchers to use chemotherapy to treat cancer, first starting research in the late 1940s alongside her father, Dr. Louis Wright. As one of the highest-ranking Black women in medicine during her time, she was also a co-founder of the American Society of Clinical Oncology (ASCO), shaping the future of cancer care.
-
On the last day of February, we'll be celebrating #RareDiseaseDay. Rare diseases are conditions that affect fewer than 200,000 people in the United States. There are more than 10,000 known rare diseases (impacting 1 in 10 Americans). Fewer than 5% of all rare diseases have an FDA-approved treatment. PharPoint has extensive experience supporting sponsors who are investigating treatment options for patients living with rare diseases. To learn more about how we can support your current or upcoming rare disease trial, reach out to our team.
-
-
Continuing our series on Black innovators in healthcare and research, this week's highlight is on Dr. Patricia Bath, an ophthalmologist, research scientist, and advocate for blindness prevention, treatment, and cure. As the first Black female doctor to receive a medical patent, Dr. Bath invented the Laserphaco Probe, a device that revolutionized cataract surgery and restored sight to individuals who were deemed blind prior to the invention. Dr. Bath's device is still used on a global scale to date.
-
Meet Maegan F., a Statistical Programmer II at PharPoint, who turned her passion for math and teaching into a rewarding career in clinical research. With a master’s in statistics, she contributes to the advancement of clinical trials while flourishing in a collaborative and growth-focused environment. Read her story and discover what she enjoys most about being part of the PharPoint team! ?? https://buff.ly/3Es3gRx https://buff.ly/3EqgzSu #MeetThePharPointTeam #LifeatPharPoint
-
-
Need support from an experienced medical writer for your upcoming trial? ?? Learn more about PharPoint's medical writing services: https://lnkd.in/gUgng2MC
-
-
This month, we’re sharing powerful clinical research stories, expert career advice, and exciting opportunities at PharPoint Research. Discover how clinical trials change lives, what patient-centric research truly means, and how to stand out in today’s job market. Plus, explore our open roles and connect with us at upcoming career fairs! #ClinicalResearch #CareerTips #CROIndustry